Prediction of Adverse Perinatal Outcome for Preeclampsia in Sichuan Province of China
Sponsor: Chengdu Women's and Children's Central Hospital
Listed as NCT01804751, this observational or N/A phase trial focuses on Preeclampsia and remains ongoing. Sponsored by Chengdu Women's and Children's Central Hospital, it has been updated 8 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Jun 2025 — Present [monthly]
Unknown
-
Sep 2024 — Jun 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Nov 2022 — Jul 2024 [monthly]
Unknown Status
-
Jan 2021 — Nov 2022 [monthly]
Unknown Status
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Unknown Status NA
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chengdu Women's and Children's Central Hospital
- Guang'an people's hospital of Sichuan province
- Luzhou Medical College
- Nanchong Central Hospital
- Sichuan Academy of Medical Sciences
- Sichuan Provincial Maternal and Child Health Care Hospital
- Suining Central Hospital
- The First People's Hospital of Neijiang
- West China Second University Hospital
- pengzhou shi fuyou baojianyuan
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.